BIOCON VALLEY GMBH
Medical Technology · Vorpommern-Greifswald
BIOCON VALLEY GMBH is a medical technology company based in Vorpommern-Greifswald, Germany. The company operates in the German medical devices market under the EU Medical Device Regulation (MDR 2017/745).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
BIOCON VALLEY GMBH Address & Contact
BIOCON VALLEY GMBH at a Glance
BIOCON VALLEY GMBH in the district of Vorpommern-Greifswald is a company specialized in biotechnology and medical technology products in Mecklenburg-Vorpommern. The company is part of the Biocon Valley cluster in the Greifswald-Stralsund region, which has developed into a growing biotechnology and medical technology location in Northeast Germany. BIOCON VALLEY focuses on the development and distribution of bio-based medical products and biomaterials. Key areas of focus include particularly innovative solutions for wound care, regenerative medicine, and implantable medical devices, characterized by state-of-the-art research approaches and many years of experience in biotechnology.
Services and Products
The range of services offered by BIOCON VALLEY GMBH includes bio-based medical products, biomaterials, and biotechnological services for the healthcare industry. The company collaborates closely with the University of Greifswald and the University Hospital Greifswald, developing products at the interface of biotechnology and medical technology. All products are developed in compliance with MDR and meet the requirements for clinical use. The offered products include specially developed hydrogels used for the treatment of chronic wounds, as well as biocompatible materials for orthopedic and dental applications. These products are distinguished not only by their efficacy but also by their high safety and biocompatibility, making them an excellent choice for medical professionals.
Regulatory Classification
BIOCON VALLEY GMBH is subject to the strict guidelines of the European Medical Device Regulation (MDR), which ensures that all products are thoroughly tested and evaluated before market launch. The company has implemented a qualified quality management system that covers all aspects of product development and manufacturing. As part of the cluster, BIOCON VALLEY proactively collaborates with authorities and research institutions to meet regulatory requirements while simultaneously developing innovative solutions. This close collaboration promotes not only compliance with standards but also enables the development of groundbreaking products that address the ever-changing needs of the healthcare market.
Location Vorpommern-Greifswald / Mecklenburg-Vorpommern
The district of Vorpommern-Greifswald in Northeastern Germany is home to the University of Greifswald, which serves as an academic partner for biotechnological innovations. The Biocon Valley cluster has established itself as an important center for medical technology and biotechnology in Northeast Germany and benefits from funding programs for structurally weak regions. Furthermore, the geographical location allows for excellent connections to national and international markets, which is of great importance for the expansion and marketing of products. The economic dynamism of the region is fostered by exchanges with other companies and start-ups that are also pursuing innovative approaches in medical technology. This interdisciplinary exchange creates a creative environment that plays a crucial role in the development of new products and sustainably strengthens the market position of BIOCON VALLEY GMBH.
Special Features and Future Perspectives
BIOCON VALLEY GMBH is committed not only to the development of high-quality products but also to sustainable manufacturing processes. The company aims to minimize ecological footprints in the production of medical products by using resource-efficient raw materials and implementing environmentally friendly technologies. This responsibility towards the environment is expected to play a central role in the company’s strategy in the future. Additionally, BIOCON VALLEY plans to expand its research activities and to broaden its product range with innovative bio-based products developed with consideration for individual patient needs. Innovative approaches in personalized medicine are at the top of the agenda to set new standards not only on the product side but also in patient treatment.
More medical technology companies: Medical Technology Overview | Pharmaceutical Companies | Laboratories
Frequently asked questions about BIOCON VALLEY GMBH
What does BIOCON VALLEY GMBH do?
BIOCON VALLEY GMBH is a company in the medical technology sector based in Vorpommern-Greifswald. The company develops, manufactures or distributes medical devices, instruments or systems for use in healthcare facilities.
Where is BIOCON VALLEY GMBH based?
BIOCON VALLEY GMBH is based in Vorpommern-Greifswald. Detailed information can be found on the company website.
In which area of medical technology does BIOCON VALLEY GMBH operate?
BIOCON VALLEY GMBH operates in the medical technology sector and offers solutions for healthcare facilities, hospitals and practices. The exact areas of activity can be found on the company website.
More Medical Technology in Vorpommern-Greifswald
Medical Technology in Germany
Related areas in healthcare
Medical Technology by location
About Medical Technology
Germany's medical technology sector is one of the most important in the world. With annual revenues of approximately EUR 36 billion and more than 1,400 companies, Germany ranks as the third-largest medical technology market globally (SPECTARIS 2023), after the United States and Japan. The sector encompasses the development, manufacture and distribution of an extraordinarily wide range of products: in-vitro diagnostic (IVD) devices, medical imaging systems (CT, MRI, ultrasound), implants such as hip and knee prostheses, cardiac pacemakers, surgical instruments, hospital beds, wound care products and medical software classified as a Software as a Medical Device (SaMD). In Germany and across the European Union, medical devices must comply with the EU Medical Device Regulation (MDR 2017/745), which replaced the former Medical Devices Directive (MDD 93/42/EEC). Devices are classified into risk classes I, IIa, IIb and III. Higher-risk classes require a conformity assessment by a designated Notified Body (benannte Stelle) before a CE mark can be affixed. The CE mark signals that the product meets EU safety, performance and quality requirements and may be placed on the European market. Key medtech clusters in Germany include the Munich and Nuremberg region in Bavaria, the Rhine-Main area in Hesse, Tuttlingen in Baden-Württemberg (known as the world capital of surgical instruments) and the Hamburg metropolitan area. This directory lists CE-certified manufacturers, distributors and suppliers across the German medtech sector with full contact details.
Germany as a Global Medical Technology Hub
Germany's position as the world's third-largest medical technology market is underpinned by a combination of industrial engineering excellence, a well-funded healthcare system and a highly productive research landscape. The German medtech sector is characterised by a large number of small and medium-sized enterprises (SMEs) that are often hidden champions (Weltmarktführer) in specialised niches. Unlike the pharmaceutical sector, where large corporations dominate, the medtech industry is more fragmented and innovative, with frequent spin-offs from university hospitals and engineering faculties. Key product categories include imaging systems (MRI, CT, X-ray, ultrasound), endoscopy and minimally invasive surgical tools, orthopaedic implants, cardiovascular devices, in-vitro diagnostics, dental equipment, ophthalmic devices, wound care systems and hospital IT and medical software. Germany is particularly renowned for its surgical instrument manufacturing, centred in Tuttlingen, Baden-Württemberg, which supplies operating theatres worldwide. The annual Medica trade fair in Düsseldorf is the world's largest medical technology exhibition and serves as a global industry showcase.
EU MDR Compliance and CE Marking for German Manufacturers
The EU Medical Device Regulation (MDR 2017/745) replaced the former Medical Devices Directive (MDD 93/42/EEC) and has applied in full since May 2021, with transition periods for legacy devices extended to 2028 in some cases. For German manufacturers selling in the EU market, MDR compliance is a legal necessity. The regulation introduced significantly strengthened requirements compared to the old MDD: more rigorous clinical evidence requirements, mandatory post-market clinical follow-up (PMCF), unique device identification (UDI) registration in the EUDAMED database, increased obligations for Notified Bodies, and stricter rules for software as a medical device (SaMD). The risk classification system under MDR uses four classes (I, IIa, IIb, III) based on the intended purpose, duration of use and body contact of the device. Manufacturers must appoint an authorised representative in the EU if they are not themselves based in an EU member state, and they must maintain a quality management system. In Germany, the Bundesnetzagentur and state authorities support MDR enforcement alongside BfArM.
Innovation and Research in German Medtech
Germany's medtech innovation ecosystem benefits from close collaboration between industry, university hospitals (Universitätsklinika), applied research institutes (such as those of the Fraunhofer and Helmholtz networks) and health technology assessment bodies. The Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) and the Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) play important roles in assessing which new medical technologies are eligible for reimbursement by statutory health insurance (GKV). This reimbursement pathway, known as the NUB process (Neue Untersuchungs- und Behandlungsmethoden) for hospital technologies, is a key milestone for commercial success in Germany. Innovative devices that receive a positive NUB assessment can be reimbursed at negotiated rates by statutory insurers, providing a significant market access advantage.
Innovation Fields and Future Technologies
The German medical technology sector is driving numerous future fields forward. AI-supported diagnostics and image analysis are revolutionising radiology and pathology; algorithms for the early detection of cancer and cardiovascular disease are increasingly receiving CE approvals as Software as a Medical Device (SaMD). Robot-assisted surgical systems, led by products from Siemens Healthineers, Brainlab and Karl Storz, are improving precision in complex procedures. Minimally invasive technologies, implantable pacemakers and intelligent prostheses with sensory feedback demonstrate the breadth of innovation. Point-of-care diagnostics enables rapid tests directly in the doctor's surgery or at the bedside. Telemedicine and digital patient records promote networking between medical devices and clinical workflows. The Federal Ministry of Education and Research (BMBF) funding programme specifically supports the development of innovative medical technology products through cooperation between industry and universities.
What does the medical technology sector cover?
Medical technology encompasses the development, manufacture and distribution of medical devices, instruments, software and accessories used to diagnose, prevent, monitor or treat diseases. Germany ranks among the world's leading medical technology hubs.
How are medical devices approved in Germany?
Medical devices in Germany and the EU must comply with the EU Medical Device Regulation (MDR 2017/745) and carry the CE mark. Depending on the risk class, conformity assessments by notified bodies are required.
Where can I find medical technology companies in Germany?
Medical technology companies in Germany can be found through industry associations such as SPECTARIS, BVMed or ZVEI, and via the EUDAMED EU database for registered manufacturers. Sanoliste provides a searchable directory of manufacturers, distributors and suppliers across the German medical technology sector.
How many medical technology companies are there in Germany?
Germany has more than 1,400 medical technology companies generating annual revenues of approximately EUR 36 billion (SPECTARIS 2023), making it the third-largest medical technology market in the world. The majority of companies are small and medium-sized enterprises (SMEs), many of which are world market leaders in their niche.
What are the risk classes for medical devices under the EU MDR?
The EU Medical Device Regulation (MDR 2017/745) classifies medical devices into four risk classes: Class I (lowest risk, e.g. bandages, glasses frames), Class IIa (medium risk, e.g. hearing aids, contact lenses), Class IIb (higher medium risk, e.g. infusion pumps, ventilators) and Class III (highest risk, e.g. implantable cardiac devices, neurosurgical instruments). Higher classes require more rigorous conformity assessment by a Notified Body.
Where are the main medical technology clusters in Germany?
Germany's medical technology industry is concentrated in several regional clusters. Bavaria (particularly Munich and Nuremberg) and Baden-Württemberg (notably Tuttlingen, globally known for surgical instruments) are the two strongest regions. Other significant clusters include the Rhine-Main area in Hesse, the Hamburg metropolitan region, the Ruhr area in North Rhine-Westphalia and the Berlin-Brandenburg region.
What is a Notified Body (benannte Stelle) and why does it matter?
A Notified Body (benannte Stelle) is an independent third-party organisation designated by an EU member state to assess whether medical devices meet the requirements of the MDR before they can carry the CE mark. For Class IIa, IIb and III devices, manufacturers must have their quality management system and technical documentation assessed by a Notified Body. In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) oversees market surveillance, while several German organisations hold Notified Body status under the MDR.